{"words": ["examine", "association", "new", "antipsychotic", "use", "mortality", "6", "months", "among", "older", "adults", "cognitive", "impairment", "variation", "risk", "frailty", "conducted", "retrospective", "cohort", "study", "older", "aged", "home", "care", "clients", "ontario", "canada", "using", "linked", "administrative", "health", "clinical", "databases", "included", "clients", "dementia", "significant", "cognitive", "impairment", "assessed", "april", "2008", "march", "2013", "frailty", "defined", "using", "validated", "index", "exposed", "newly", "dispensed", "antipsychotic", "6", "months", "post", "cohort", "entry", "claims", "year", "prior", "drug", "index", "date", "matching", "defined", "unexposed", "clients", "index", "date", "matching", "age", "sex", "frailty", "assessment", "year", "propensity", "score", "outcome", "time", "death", "following", "index", "date", "hazards", "models", "used", "number", "needed", "harm", "6", "months", "estimated", "cumulative", "incidence", "function", "4955", "matched", "pairs", "new", "antipsychotic", "users", "showed", "significantly", "increased", "hazard", "mortality", "1", "3", "6", "months", "relative", "unexposed", "highest", "risk", "observed", "first", "month", "hazard", "ratio", "hr", "95", "ci", "1", "month", "risk", "significantly", "higher", "robust", "hr", "95", "ci", "vs", "frail", "hr", "95", "ci", "p", "clients", "number", "needed", "harm", "vary", "frailty", "lower", "men", "women", "mortality", "highest", "first", "month", "following", "exposure", "varied", "significantly", "client", "frailty", "greater", "among", "men", "among", "women"], "authors": [["Maxwell", "Colleen J", "CJ", "Schools of Pharmacy and Public Health and Health Systems, University of Waterloo, Waterloo, Canada."], ["Campitelli", "Michael A", "MA", "Institute for Clinical Evaluative Sciences, Toronto, Canada."], ["Hogan", "David B", "DB", "Department of Medicine, University of Calgary, Calgary, Canada."], ["Diong", "Christina", "C", "Institute for Clinical Evaluative Sciences, Toronto, Canada."], ["Austin", "Peter C", "PC", "Institute for Clinical Evaluative Sciences, Toronto, Canada."], ["Amuah", "Joseph E", "JE", "School of Epidemiology, Public Health, and Preventive Medicine, University of Ottawa, Ottawa, Canada."], ["Lapane", "Kate", "K", "Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA."], ["Seitz", "Dallas P", "DP", "Division of Geriatric Psychiatry, Queen's University, Kingston, Canada."], ["Gill", "Sudeep S", "SS", "Providence Care, Kingston, Canada."], ["Gruneir", "Andrea", "A", "Institute for Clinical Evaluative Sciences, Toronto, Canada."], ["Wodchis", "Walter P", "WP", "Institute for Clinical Evaluative Sciences, Toronto, Canada."], ["Bronskill", "Susan E", "SE", "Institute for Clinical Evaluative Sciences, Toronto, Canada."]], "title": "Relevance of frailty to mortality associated with the use of antipsychotics among community-residing older adults with impaired cognition.", "year": null, "sentences": ["To examine the association between new antipsychotic use and mortality over 6\u00a0months among community-based older adults with cognitive impairment, and variation in risk by frailty and sex.We conducted a retrospective cohort study of older (aged 66+) home care clients in Ontario, Canada, using linked administrative health and clinical databases.", "Included were clients with dementia and/or significant cognitive impairment assessed during April 2008 to March 2013.", "Frailty was defined using a validated 72-item index.", "Exposed were those newly dispensed an antipsychotic in the 6\u00a0months post cohort entry, with no such claims in the year prior to drug index date.", "Two-stage matching defined unexposed clients and their index date (matching on age, sex, frailty, assessment year, and propensity score).", "Outcome was time to death following index date.", "Cause-specific hazards models were used, and number needed to harm at 6\u00a0months was estimated from cumulative incidence function curves.Among 4955 matched exposed-unexposed pairs, new antipsychotic users showed a significantly increased hazard of mortality at 1, 3, and 6\u00a0months relative to unexposed, with the highest risk observed in the first month (hazard ratio [HR]\u00a0=\u00a02.08 [95% CI, 1.79-2.43]).", "At 1\u00a0month, risk was significantly higher for robust (HR\u00a0=\u00a03.72 [95% CI, 2.45-5.66]) vs frail (HR\u00a0=\u00a01.74 [95% CI, 1.40-2.17], P\u00a0=\u00a0.002) clients.", "The number needed to harm was 22.7 and did not vary by frailty but was lower for men (14.9) than for women (35.0).Risk of antipsychotic-associated mortality was highest in the first month following exposure, varied significantly by client frailty, and was greater among men than among women."], "id": "29318705", "text": "To examine the association between new antipsychotic use and mortality over 6\u00a0months among community-based older adults with cognitive impairment, and variation in risk by frailty and sex.We conducted a retrospective cohort study of older (aged 66+) home care clients in Ontario, Canada, using linked administrative health and clinical databases. Included were clients with dementia and/or significant cognitive impairment assessed during April 2008 to March 2013. Frailty was defined using a validated 72-item index. Exposed were those newly dispensed an antipsychotic in the 6\u00a0months post cohort entry, with no such claims in the year prior to drug index date. Two-stage matching defined unexposed clients and their index date (matching on age, sex, frailty, assessment year, and propensity score). Outcome was time to death following index date. Cause-specific hazards models were used, and number needed to harm at 6\u00a0months was estimated from cumulative incidence function curves.Among 4955 matched exposed-unexposed pairs, new antipsychotic users showed a significantly increased hazard of mortality at 1, 3, and 6\u00a0months relative to unexposed, with the highest risk observed in the first month (hazard ratio [HR]\u00a0=\u00a02.08 [95% CI, 1.79-2.43]). At 1\u00a0month, risk was significantly higher for robust (HR\u00a0=\u00a03.72 [95% CI, 2.45-5.66]) vs frail (HR\u00a0=\u00a01.74 [95% CI, 1.40-2.17], P\u00a0=\u00a0.002) clients. The number needed to harm was 22.7 and did not vary by frailty but was lower for men (14.9) than for women (35.0).Risk of antipsychotic-associated mortality was highest in the first month following exposure, varied significantly by client frailty, and was greater among men than among women.", "doi": "10.1002/pds.4385", "journal": ["Pharmacoepidemiology and drug safety", "Pharmacoepidemiol Drug Saf"], "date": "2018-01-18_23:41:05"}